Nobivac Parvo-C
Nobivac Parvo-C
Authorised
- Canine parvovirus, strain 154, Live
Product identification
Medicine name:
Nobivac Parvo-C
Nobivac Parvo-C
Active substance:
- Canine parvovirus, strain 154, Live
Target species:
-
Dog
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Canine parvovirus, strain 154, Live10000000.00/tissue culture infective dose 501.00millilitre(s)
Pharmaceutical form:
-
Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
-
Dog
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07AD01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Ireland
Package description:
- Clear, Glass Type I (Ph.Eur) single vials with halogenobutyl rubber stopper, closed with a colour coded aluminium cap.Cardboard containing 50 single dose vials of the diluent
- Clear, Glass Type I (Ph.Eur) single vials with halogenobutyl rubber stopper, closed with a colour coded aluminium cap.Cardboard containing 10 single dose vials of the diluent
- Clear, Glass Type I (Ph.Eur) single vials with halogenobutyl rubber stopper, closed with a colour coded aluminium cap.Cardboard containing 50 single dose vials of the vaccine
- Clear, Glass Type I (Ph.Eur) single vials with halogenobutyl rubber stopper, closed with a colour coded aluminium cap.Cardboard containing 10 single dose vials of the vaccine
- Clear, Glass Type I (Ph.Eur) single vials with halogenobutyl rubber stopper, closed with a colour coded aluminium cap.Cardboard containing 50 single dose vials. The diluent is packed together with the vaccine
- Clear, Glass Type I (Ph.Eur) single vials with halogenobutyl rubber stopper, closed with a colour coded aluminium cap.Cardboard containing 10 single dose vials. The diluent is packed together with the vaccine
- Clear, Glass Type I (Ph.Eur) single vials with halogenobutyl rubber stopper, closed with a colour coded aluminium cap.Plastic box containing 50 single dose vials of the diluent
- Clear, Glass Type I (Ph.Eur) single vials with halogenobutyl rubber stopper, closed with a colour coded aluminium cap.Plastic box containing 10 single dose vials of the diluent
- Clear, Glass Type I (Ph.Eur) single vials with halogenobutyl rubber stopper, closed with a colour coded aluminium cap.Plastic box containing 50 single dose vials of the vaccine
- Clear, Glass Type I (Ph.Eur) single vials with halogenobutyl rubber stopper, closed with a colour coded aluminium cap.Plastic Box containing 10 single dose vials of the vaccine
- Clear, Glass Type I (Ph.Eur) single vials with halogenobutyl rubber stopper, closed with a colour coded aluminium cap.Plastic box containing 10 single dose vials. The diluent is packed together with the vaccine
- Clear, Glass Type I (Ph.Eur) single vials with halogenobutyl rubber stopper, closed with a colour coded aluminium cap.Plastic box containing 50 single dose vials. The diluent is packed together with the vaccine
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Intervet (Ireland) Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- Intervet International B.V.
Responsible authority:
- Health Products Regulatory Authority
Authorisation number:
- VPA10996/167/001
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0160/001
Concerned member states:
-
Norway
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 3/05/2024
How useful was this page?:
